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ABSTRACT
The release of modified mosquitoes to suppress/replace vectors constitutes a promising tool for vector control and
disease prevention. Evidence regarding these innovative modification techniques is scarce and disperse. This work
conducted a systematic review, gathering and analysing research articles from PubMed and Biblioteca Virtual em
Saúde databases whose results report efficacy and non-target effects of using modified insects for disease
prevention, until 2016. More than 1500 publications were screened and 349 were analysed. Only 12/3.4% articles
reported field-based evidence and 41/11.7% covered modification strategies’ post-release efficacy. Variability in the
effective results (90/25.7%) questioned its reproducibility in different settings. We also found publications reporting
reversal outcomes 38/10.9%, (e.g. post-release increase of vector population). Ecological effects were also reported,
such as horizontal transfer events (54/15.5%), and worsening pathogenesis induced by natural wolbachia (10/2.9%).
Present work revealed promising outcomes of modifying strategies. However, it also revealed a need for field-based
evidence mainly regarding epidemiologic and long-term impact. It pointed out some eventual irreversible and
important effects that must not be ignored when considering open-field releases, and that may constitute
constraints to generate the missing field evidence. Present work constitutes a baseline of knowledge, offering also a
methodological approach that may facilitate future updates.
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Introduction
Vector-borne diseases have a wide impact on human
health being a mandatory topic on global health
agendas [1,2]. Even with the significant reduction
of the global burden of malaria since the beginning
of the century, in 2016, this infectious disease was
still responsible for 445,000 deaths [3]. Due to
human population growth, globalization, and climate
change, arboviral diseases outbreaks have been
increasing in frequency, expansion, diversity, and
severity [4]. Only dengue’s incidence grew more
than 30-fold in the last 50 years [5]. Although arbo-
viruses dispersal is partially conditioned by the
environmental constraints that limit the distribution
of its main vectors, outbreaks of diseases such as
yellow fever, chikungunya, and Zika have been
reported all over the world [6–10]. The severity of
Zika fetal malformations during 2015/2016 epi-
demics turn it a public health emergency of inter-
national concern according to World Health
Organization [8]. The lack of effective approved vac-
cines for some of these infections and the increase
of insecticide resistance in its most competent vec-
tors, impose an urgent need for innovative effective
strategies to minimize these diseases [9,10].
The release of modified insects is considered a
promising approach for prevention and control of
vector-borne diseases. Innumerous techniques and
insects’ modification strategies had been laboratorial
tested, all of them fitting one of the two broad
approaches: (i) modification and release of sterile
insects aiming the reduction/eradication of natural
vector populations (suppression approach/vector con-
trol approach) or (ii) modification and release of
insects refractory to pathogen transmission aiming
the replacement of natural vector populations (repla-
cement approach/transmission prevention approach).
Open releases of modified insects have been occur-
ring all over the world in an attempt to cope the
unprecedented vector-borne diseases burden [11].
However, none of these modifying technologies has
yet been approved by the WHO’s Vector Control
Advisory Group [12].
Few studies reported the effectiveness of mos-
quito modification strategies, and even less their
eventual effects exploring them only barely and
theoretically [13]. Important reviews on this topic
were recently published, but corresponding to the
perspective of the author regarding the subject or
a summary of the authors’ selection of publications
[14,15]. This work presents a unique structured
review on the use of modified insects to control
and prevent vector-borne diseases, gathering,
exploring, and classifying evidence available up to
2016 regarding efficacy and (non-target) effects of
these modifying techniques.
Methods
The present work is enrolled in a bigger project whose
aim is the description of the strengths/weaknesses/
opportunities/threats of modified insects for disease
prevention (genetic, radiation-based, or other modifi-
cations). During analysis and reviewers’ consensus, it
was realized that all evidence found constituting
strengths/weaknesses/opportunities/threats of the
insects’ modification for disease prevention were
fitting in two main themes: the efficacy and the non-
target effects of the insects’ modifications. Hence,
results were extracted and are presented according to
this classification.
Search strategy
To identify relevant documents focusing on strengths,
weaknesses, opportunities, and threats of modifying
insects to prevent diseases, two electronic databases
(PubMed and Biblioteca Virtual em Saúde, BVS)
were searched using combinations of MeSH terms
and free text words such as “organisms, genetically
modified” (MeSH), “wolbachia,” “lethal,” “sterile
insect,” “vector-borne,, “replacement,” and “suppres-
sion.” To help increase sensitivity and specificity, com-
binations of different search strings were used for each
electronic database. Results from all searches were
downloaded into Mendeley program (Elsevier); dupli-
cates were withdrawn automatically using Mendeley
and verified manually, followed by the inclusion pro-
cess implementation.
Study selection
Publications were included in the study when all of the
following inclusion criteria were met:
(1) Research articles, i.e. publications structured as
Introduction, Material and Methods, and Results/
Discussion, or similar.
(2) Available as Free Full-Text at NOVA Discovery
platform.
(3) Written in English, French, Portuguese, or
Spanish.
(4) Published until the date of the search (1 March
2016).
(5) Publications covering modified insects or the
modifications itself. It was considered “modifi-
cation” any process, species, or condition,
described in the literature as able to be used to
modify insects (rather genetic or other type of
modification), even if not explicit in the collected
paper.
(6) Publications whose results explicitly report
strengths, weaknesses, opportunities, and threats
of the modifications (or eventual modifications)
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concerned with health impact and/or biological
impact
(7) Publications whose studies were performed in
Insect or Mammal species, rather in vitro, in
vivo, ex vivo, or in archetypal modelled species.
These inclusion criteria (point 5) cover publications
regarding several types of modifications, such as Wol-
bachia-based, radiation-based, genetic-based, etc. and
in the case of ‘Wolbachia’ search term it included both
natural or artificial Wolbachia infections.
Also, even tough most work on this area has been
done for mosquito-borne diseases’ prevention, the
term ‘insects’ were selected instead of ‘mosquitoes’
(point 7). This criteria aims to not exclude publi-
cations reporting modifications often applied to mos-
quitoes when applied to other insects, namely for
laboratory ease and also to include non-mosquitoes
insect vectors such as Glossinas spp.
A two-stage inclusion process was applied. All refer-
ences were initially screened by title and abstract and
included in the study if they met the selection criteria.
In the second stage, the full-text reading of each publi-
cation was undertaken. To establish consensus in cri-
teria application, part of the publications (5% of the
1st screening, and 50% of the 2nd screening) were
screened by two reviewers (inter-reviewer check). Dis-
agreements were resolved by discussion. At the end of
the 2nd screening and after criteria had been discussed,
the full-text screening was repeated by one reviewer to
ensure homogeneity of the criteria during the process
(temporal check). All documents considered relevant
went to the next phase of extracting data and analysis.
Data synthesis and analysis
Data were extracted from the included publications
into a digital data-extraction form. Two investigators
performed data extraction and analysis of 50% of
the included publications (inter-reviewer check). All
extracted data were structured into two major
themes, efficacy and effects of the modification strat-
egies, and each of them divided into several topics
and sub-topics (see more detailed information in
Results section). These hierarchical categories were
defined by the two reviewers through a consensual
process. Disagreements were resolved by discussion.
When consensus was attained, categorization and
analysis of all included articles were re-checked in
order to ensure a homogeneous analysis (temporal
check). According to the evidence reported, publi-
cations were classified into as many categories as
possible, in order to reduce the likelihood of missing
key points in the data. It was also extracted infor-
mation regarding the year, type of study (laboratory,
semi-field, field, and computational modelling),
species involved in the experiments, and
modification strategy (Wolbachia, anti-pathogen
Transgenesis, lethal Transgenesis, etc.). As to Wolba-
chia-based studies, publications were classified
according to the endosymbiont origin: natural
occurrence, artificially introduced or removed from
natural or artificially infected hosts. The classifi-
cation regarding the type of study was used as a
proxy of the publication robustness, considering
semi-field and field studies the most robust ones,
and computational modelling and laboratorial the
less robust. Apart from qualitative analysis, descrip-
tive statistics analysis was performed. The softwares
Excel (Microsoft Office, Windows 10) and NVivo
10 (QSR International Pty Ltd, Doncaster, Victoria,
Australia) were used during the analysis. Results
are presented by theme, modification strategy and
species, publications are also referred according to
their chronological order on the manuscript’s sec-
tions, tables, and supplementary information. This
literature review followed the proceeding of a
PRISMA methodology (S1 Checklist).
Results
Databases searches resulted in a total of 1567 publi-
cations (Figure 1). Following the removal of dupli-
cates, 1205 references were selected. After the two-
stage selection process, 377 articles were included in
the study and 349 publications were analysed. Refer-
ences from analysed publications were ordered from
1 up to 349 and cited in italic for differentiation
from manuscript’s references listed in the end of
the manuscript (see full list of analysed publications
and summary of analysis in S1 Appendix).
From the 349 publications selected for analysis, 340/
97.1% were published after the year 2000. The majority
constituted laboratory studies, i.e. performed in a con-
trolled experimental environment (310/88.6%) and
referred to Wolbachia or other symbiont-based modifi-
cation strategy (307/88.0%). Several organisms’ species
integrated in the experiments of the analysed publi-
cations: five genera of insects vectors (Aedes, Anopheles,
Culex, Mansonia, Phlebotomus, and Glossina), 54 genera
of non-vector insects, and four mammals genera (see all
data regarding quantitative analysis in S1 Figure).
In what concerns the content of the publications,
two major themes emerged from the analysed research
articles: (i) efficacy of the modification strategies and
(ii) non-target effects induced by the modifications.
Both themes (efficacy and effects) were divided into
several topics (see Figure 2).
Efficacy outcomes were also divided into effective
outcomes – reporting the success of the modifi-
cation strategy – and ineffective outcomes – report-
ing the failure of the modification strategy.
Ineffective outcomes include outcomes that (i)
achieved no results, (ii) described indirect results
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that call into question the efficacy of the modifi-
cation strategy, and/or (iii) reported reversal results,
i.e. that lead to the reverse of the aim of the
modification strategy. There were more publications
contributing to efficacy (237/67.7%) than publi-
cations with results regarding effects (156/44.6%)
(Figure 3). Regarding themes and topics’ analysis,
each publication may have contributed to more
than one category.
In what concerns publications covering efficacy out-
comes, there were more publications reporting ineffec-
tive outcomes (164/69.2%) than publications reporting
effective ones (150/63.3%). Out of the latter, only 41/
27.3% constitute main effective outcomes (regarding
its release, epidemiologic and long-term efficacy), and
out of the former, 38/23.2% constitute reversal out-
comes (Figure 3).
Next sections summarize the analysis by themes and
topics, and by modification strategies as follows: (i)
Wolbachia and other symbiont-based modification
strategies and (ii) transgenesis and other non-sym-
biont-based modification strategies. Some modifi-
cations are the combination of the two above types of
modification strategies. Examples of those are (i) Para-
trangenesis, i.e. the introduction of a transgene in a
symbiont bacteria infecting the insect (rather than
introducing the transgene in the genome of the insect
itself) (2); (ii) the simultaneous introduction of a Wol-
bachia and a transgene in the same organism (3) (both
included in “Wolbachia and other symbiont-based”
section); and (iii) transgenesis using Wolbachia as
gene drive (4–9) (included in “Transgenesis and
other” section).
Efficacy
Wolbachia and other symbiont-based
modification strategies (effective and ineffective
outcomes)
A total of 195/82.3% research articles, out of the 237
with efficacy outcomes, presented results regarding
the efficacy of Wolbachia or other symbiont-based
insect modifications (111/56.9% reported effective out-
comes, 145/74.4% reported ineffective outcomes, nTo-
tal = 195). One publication reported the efficacy of
other symbiont-based insect modification strategy (a
Sodalis modified by paratrangenesis) (2), and two pub-
lications referred to computational studies using arche-
typal modelled endosymbionts (10),(11). Efficacy
results covered all the topics (Modification, Technique,
Fitness, Release, Epidemiology, Long-term, and
Figure 1. PRISMA Flowchart reporting the number of publications in each stage of the review.
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Variability) as presented in Figure 4 and described in
the following paragraphs. Wolbachia-related efficacy
results were based on artificial Wolbachia infections
in all topics except on variability topic which results
came both from natural and artificial Wolbachia
infections.
Modification
According to analysed publications, different Wolba-
chia strains were microinjected into several insect
species, leading to a successful germline infection of
the insect (stable transinfection). Stable transinfections
were reported in the following insect species: Aedes
aegypti (12–31), Aedes albopictus (32–36), Aedes poly-
nesiensis (37),(38), Anopheles gambiae (39), Anopheles
stephensi (40),(39),(41), and Culex tarsalis (42) (vector
mosquitoes), and Bemisia tabaci (whitefly) (43), Cera-
titis capitata (medfly) (44), Drosophila melanogaster
(fruit fly) (45),(46), Drosophila simulans (fruit fly)
(47–50),(45),(51),(46),(52), Ephestia kuehniella (but-
terfly) (53),(54), Laodelphax striatellus (planthopper)
(55) (non-vector insects). Apart from transinfections,
analysed articles also described other types of Wolba-
chia successful introduction such as transient somatic
infection (56–58), infections in cell lines (59–65), ex
vivo organ culture (66), outcrossing (67),(68), and
introgression (69–71),(45),(72),(19),(67),(73–77). One
article reported the loss of wMel on an Aedes albopictus
cell line 12 passages post-infection (61).
Technique
In what concerns the traits that ensure the Wolbachia
effectiveness, several publications reported high cyto-
plasmic incompatibility (CI), i.e. the survival of
offspring from infected females (>90%) and/or perfect
(100%) maternal transmission, i.e. the transmission of
Wolbachia to the insect host’s offspring, on vectors
species mainly in Aedine species (12),(17),(19),(68),
(27),(30),(74),(78–80),(75),(37), but also in Anopheles
stephensi (40),(39), and Culex pipiens quinquefasciatus
(81),(82). Wolbachia-induced pathogen protection was
first reported in Drosophilinae species, protecting from
Figure 2. Schematic representation of the themes, topics, and type of outcomes described in the “Results” section.
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infection of several RNA virus (83). Later, pathogen
protection induced by artificial introduction of Wolba-
chia was also demonstrated in several vector species:
not only in those naturally not infected by Wolbachia,
such as Aedes aegypti (14),(16),(19),(20),(28) and Ano-
pheles stephensi (40),(84); but also in those that natu-
rally host it, such as Aedes albopictus (35),(85),(86),
Aedes polyniensis (37),(38), Anopheles gambiae (57),
(58), and Culex quinquefasciatus (87). In Aedine vector
species, transinfected Wolbachia blocked the
development of several human pathogens: yellow
fever virus (YF) (20), chikungunya virus (CHIKV)
(16),(20),(88),(86) three serotypes of dengue virus
(DENV1, DENV2 and DENV3) (16),(19),(28),(64),
(35),(85),(38), and the filarial nematode Brugia pahangi
(37). Wolbachia-infected Aedes aegypti was also pro-
tected against plasmodium gallinaceum (16). In Ano-
pheline species, transinfected Wolbachia induced
protection against Plasmodium falciparum, the
most virulent plasmodium species (57),(40), mod-
estly suppressed Plasmodium berghei oocyst levels
(58), and at some temperatures also protected
from Plasmodium yoelii infection (84). In Culex
pipiens quinquefasciatus, transinfected Wolbachia
diminished the West Nile virus (WNV) transmission
(87). Six publications also reported that transinfected
Wolbachia could enhance infection of some patho-
gens in vector species such as WNV in Culex tarsa-
lis (42) and in-vitro (59), Plasmodium yoelii at some
temperatures in Anopheles stephensi (84), Plasmo-
dium gallinaceum in Aedes fluviatilis (80), Plasmo-
dium relictum in Culex quinquefasciatus (89), and
DENV2 in Aedes aegypti (90). These constitute
reversal outcomes, i.e. the reverse to what was intended
with an effective Wolbachia-based modification.
Fitness
None or low fitness costs, caused by the introduction of
Wolbachia in insects species, allow the modified insect
to be reproductively competitive against their natural
counterparts, and therefore to easily invade natural
populations after its release. Analysed publications
described no or low fitness costs afterWolbachia intro-
duction in several vector insect species: Aedes aegypti
(67),(22),(24),(73),(30), Aedes albopictus (91),(78),(79),
(86), Aedes fluviliatilis (80), Aedes polyniensis (75–77),
and Culex pipens quinquefasciatus (81),(82). Some
articles reported a fitness cost that act as part of
the control strategy, i.e. constituting part of the
Figure 3. Distribution of the: (i) (above) publications whose
results contributed to each of the major themes (n = 349); (ii)
(below) publications whose results contributed to each type
of outcomes in efficacy (According to Figure 2 Primary covering
Modification, Technique, and Fitness topics, and Main covering
Release, Epidemiology, and Long-term topics) (n = 237).
Figure 4. Distribution of the publications regarding Wolbachia and other symbiont-based modification strategies, whose results
contribute to each efficacy topic, distinguishing effective/ineffective outcomes (n = 195).
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modification efficacy. These were the report of Wolba-
chia-induced life shortening of vectors (that reduce or
eliminate the time vectors can transmit the pathogen)
(16–19),(68),(34),(57) or decreased viability of desic-
cated eggs (preventing the next generation of mosqui-
toes from hatching after the dry season) (18),(68).
Despite referring to a fitness cost, since they constitute
Wolbachia traits that ensure its effectiveness, are herein
considered effective outcomes of the Technique topic.
In some casesWolbachia-induced fitness costs on mat-
ing competitiveness (41), fecundity (22),(27), (80),(34),
(41), fertility (22), larvae competitiveness (92), life span
(34), or development time (68),(25) of the modified
insect. Moreover, some publications reported Wolba-
chia-induced fitness benefits in vector insects (13),
(90),(93),(74),(92),(41),(94),(95),(82). Once fitness
benefits lead to an increase of the insect vectorial
capacity and consequently to an increase in disease
transmission, they constitute reversal outcomes.
Release
A successful release of modified insects describes either
(i) their effective invasion and establishment in the field
(replacing natural population) or (ii) incompatible
mattings between modified and natural insects (sup-
pressing the population). The release of the non-vector
Ceratitis capitata (fruit fly) males, transinfected and
inducing complete CI, led to the complete suppression
of a laboratory cage population of natural specimens
(44). Insects with introduced Wolbachia successfully
replaced natural specimens in laboratory cages (12),
(44), in semi-field cages (19),(40), and in the field,
(67),(27). Similar results were suggested by compu-
tational modelling studies (96),(30). Other articles
reported invasion but only under certain meterological
(68) or entomological conditions (26), or if some tech-
nical ordeals could be overcome (97). However, release
of Wolbachia insects also led to no/low invasion rates
(98),(99). Several studies suggested the need to release
prohibitively large number of insects (100–102). To
overcome that, two solutions were reported: releases
in a ratio of 95% male mosquitoes (requiring a mass
rear capacity) (11) or the introduction of insecticide
resistance genes along with Wolbachia in the host
insect, combined with a pre-release intervention to
reduce (adult) insect vector numbers (29), (3). The
unintended increase of the insect population after the
release of the modified insects (reversal outcomes)
was estimated by computational modelling studies
(103), some of them based on field data of wMelPop-
aegypti (100) and of superinfected Aedes albopictus
(93).
Epidemiology
Until 2016, no publications described the impact of
Wolbachia-based modified insects on human disease
incidence. However, several computational modelling
studies estimated a successful epidemiological impact
after the release of Wolbachia-insects (96),(11), specifi-
cally using wMel-aegypti combination which seems to
eliminate DENV transmission in low or moderate
transmission settings (104),(105).
Long-term
Released wMel-aegypti populations persisted in near
fixation and maintained the Wolbachia-induced
DENV protection, two years after the release (27),
(28). Laboratory and/or computational modelling
studies also revealed that Wolbachia (natural or intro-
duced) may persist over time in its symbiotic host
(106),(107),(10),(108). Despite that, the long-term
efficacy of Wolbachia-based modification strategy was
questioned due to the report of (i) a change in CI
rates or in Wolbachia density with age, time, or over
generations (109–111),(69),(112),(47),(113-115); (ii) a
change in other effective traits (45),(60); (iii) loss of
Wolbachia infection (106),(116–122); and (iv) its natu-
ral replacement by other Wolbachia strain (123–125).
Moreover, long-term efficacy was also questioned by
the risk of immigration/re-invasion of other insect
populations after the release and fixation of the
modified insect population (21),(27). How and how
much this phenomena will affect efficacy is not
known (104),(21).
Variability
Finally, also affecting Wolbachia efficacy is its variabil-
ity. It was reported that a considerable degree of varia-
bility may evolve in short evolutionary periods (126).
Several articles described Wolbachia evolution (127),
(128), including its transition from facultative parasite
to a nutritional mutualist (129) or obligatory symbiont
(130).Wolbachia density inside an insect-host changed
according to a multitude of factors, such as, host
genetic background (112),(131),(61),(132),(133),(62),
(134), presence of resistance genes (135), host gender
(109),(136),(111),(134), development stage (111), nutri-
tion (57),(41),(137), immunity status (111), presence of
pathogens (23),(83), or host microbiome (39),(138–
140). It also varied according to Wolbachia strain
(141),(142), even when coexisting in the same host
(140), insect larvae density (143), and environmental
conditions (84),(144),(145),(143),(111) (such as humid-
ity and temperature). However, Wolbachia density in
A. aegypti did not alter after repeated human blood
feeding (31), neither insecticide susceptibility of
A. aegypti changed after Wolbachia infection (36).
Somewhat surprising Aedes albopictus cell lines
infected with wStr or wAlbB showed resistance to
streptomycin (63). Wolbachia main effective outcomes
in insect vectors are presented in Table 1 and its rever-
sal outcomes in insect vectors are described in Table 2,
see the complete data (also (146–153) and (154–201))
in S1 Table.
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Table 1. Main effective outcomes of Wolbachia-based and other symbiont-based insect modification (vector insect species).
Species Wolb strain Release Epidemiology Long-term
Type of
Study Reference
Aedes aegypti wAlbB reaching infection fixation within seven
generations
Lab Xi et al., 2005a (11)
wMel/
wMelPopCLA
near fixation in 30 days-wMel (much quicker than
wMelPopCLA)
wolb-mosquitoes would be successfully maintained in
wild populations
Lab and semi
field
Walker et al., 2011
(18)
wMel near-fixation in 5 weeks / 90% infected mosquitoes
at 5 weeks after releases
Field and
Model
Hoffmann et al.,
2011 (66)
wMelPop-CLA invasion is possible under humid conditions (under
dry conditions invasion will be difficult)
Lab and
Model
Yeap et al., 2011 (67)
wMel can eliminate dengue transmission in low or
moderate transmission settings
wolb-mosquitoes once established these are not
vulnerable to invasion
Model Hughes and Britton,
2013 (103)
n.a. (achieve fixation in a comparable time but with half
mosquitoes)
the approach can be used to bolster wolb frequency if
reinvasion by uninfected mosquitoes occur.
Model Hoffmann and
Turelli, 2013 (2)
wMel Residential blocks with relatively low numbers were
more easily invaded
Field and
Model
Hoffmann et al.,
2014a (25)
wMel near fixation in both locations, but a persistent low
frequency of uninfected mosquitoes
>2 years after release (traits were reevaluated) Lab and field Hoffmann et al.,
2014b (26)
wMel >2 years after release protection persist Lab and field Frentiu et al., 2014
(27)
n.a. 66-75%reduction in DENV transmission (it may be
insufficient in high transmission settings)
Model Ferguson et al., 2015
(104)
wMel can spread effectively in different urban
environments
Lab, field and
Model
Dutra et al., 2015
(29)
An. stephensi wAlbB invasion of laboratory mosquito populations Lab and semi
field
Bian et al., 2013a
(39)
Culex pipiens If technical ordeals can be overcome, wolb can
invade vector populations
Lab and
Model
Rasgon and Scott,
2003 (96)
Glossina mors.
mors
modified
Sodalis’
Fixation of the modified tse tse flies potential to eradicate trypanosome infections in
humans, animal reservoir
Model Medlock et al., 2013
(1)
Note: Publications reporting effective outcomes in release, epidemiology and long-term topics (the ones closer to the strategy aim, that is transmission blockage or vector suppressing). Ineffective outcomes of the mentioned publications are
also presented (in italic). Lab stands for laboratorial and Model stands for computational modelling paratrangenesis.
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Transgenesis and other non-symbiont-based
modification strategies (effective and ineffective
outcomes)
A total of 37 research articles (15.6% out of the 237
with efficacy outcomes) have results regarding the
efficacy of transgenesis or other non-transgenic and
non-symbiont-based insect modification (37/100%
reported effective outcomes, 15/40.5% reported ineffec-
tive outcomes).
Two types of transgenesis were found in analysed
publications: (i) anti-pathogen transgenesis, i.e. trans-
genesis with an anti-pathogen effector gene (30 publi-
cations) (202–205),(9),(206),(7),(207), (208),(5),(209–
215),(6),(4),(216),(8),(217–225) and (ii) results on lethal
transgenesis, i.e. transgenesis with a lethality inducing
gene, covering the release of insects with a dominant
(RIDL) (three publications) (226–228), and with a
female-killing transgene (three publications) (229),
(224),(230). Two non-transgenic non-symbiont-based
insect modifications were also reported: (i) a radi-
ation-based sterilization insect technique (SIT) (one
publication) (231), and (ii) a RNAi-mediated steriliza-
tion (one publication) (232).
Not all modifications covered all efficacy topics
(Modification, Technique, Fitness, Release, and Varia-
bility). No studies reported results regarding epide-
miology efficacy using these types of modifications.
Results are described in the following paragraphs and
quantified in Figure 5.
Modification (anti-pathogen transgenesis)
Several studies described successful gene vectors
mainly transposable elements, such as Hermes and pig-
gyBac (230),(202),(205),(211),(213),(216),(218),(221),
(223),(228), but also transcription activator-like effec-
tor nuclease (TALEN) (225). Moreover, several distinct
promotors were described generating successful sex,
tissue or stage-specific expression of effector genes
(211),(212),(204),(213),(203),(217),(219),(215). Suc-
cessful insertion of an anti-pathogen effector gene
was reported in Aedes aegypti (203),(208),(211),(212),
(216),(220),(217),(224), Anopheles gambiae (204),
(213),(218),(222),(205),(207),(210),(221), Anopheles
stephensi (205),(207),(210),(214),(221), Culex pipiens
(7), Glossina morsitans morsitans (4), and in some
Table 2. Reversal outcomes of Wolbachia-based and other symbiont-based insect modification (vector insect species cell-lines not
included).
Species
Modification
Strategy Release Long-term
Type of
Study Reference
Aedes aegypti anti-pathogen
Transgenesis
(MLA*)
the risk of an accidental premature release into nature
is minimized and can be used as a back-up
transgene dispersal mechanism while not as efficient
as active drive mechanisms
Model Rasgon, 2009
(152)
Lethal Transgenesis
(RIDL)
males introduced weekly eliminated the populations
within 10–20 weeks.
Lab Wise de Valdez
et al., 2011
(169)
Lethal Transgenesis
(RIDL)
substantial suppression can be achieved if releases are
deployed in a uniform spatial pattern using strains
combining multiple lethal elements
Model Legros et al.,
2012 (170)
Lethal Transgenesis
(Female killing)
Release ratio and population size can impact mean
extinction time. Eradication may not always be
obtainable in an operationally realistic time frame
Model Robert et al.,
2013 (172)
anti-pathogen
Transgenesis
the most efficient approach for achieving spread of
anti-pathogen genes within three years is generally
to release adults of both sexes in multiple releases
over time. (the less efficient male-only release impose
less public concern)
Model Legros et al.,
2013 (163)
anti-pathogen
Transgenesis
can substantially decrease vector competence of a
natural population, even at release ratios well below
those required for population reduction. Are
considerably more robust to immigration.
Model Okamoto et al.,
2014 (167)
Lethal Transgenesis
(Female killing)
can decrease vector competence of a natural
population, at release ratios not as low that required
for anti-pathogen gene [above].
are compromised by
immigration of wild-
type mosquitoes
Model Okamoto et al.,
2014 (167)
Anopheles
stephensi
anti-pathogen
Transgenesis
(in lab cages) gradually replaced non-transgenics
mosquitoes when fed on Plasmodium-infected
blood but not when fed on non-infected blood
Lab and
Model
Marrelli et al.,
2007 (150)
anti-pathogen
Transgenesis
(in lab cages) transgenic mosquitoes invade when
maintained on Plasmodium-infected blood.
Lab and
Model
Smith, 2013
(164)
Culex pipiens sl anti-pathogen
Transgenesis
the number of transgenic mosquitoes that must be
eventually released may be low and the gene of
interest could spread in a relatively short period of
time
Lab and
Model
Rasgon et al.,
2006 (6)
Glossina
mo..morsitans
anti-pathogen
Transgenesis
experimental CI results were incorporated into a
mathematical model, confirmed that Wolbachia can
be used successfully as a gene drive
Lab and
Model
Alam et al., 2011
(3)
Note: Publications reporting reversal outcomes (reverse to the strategy aim, that is transmission blockage or vector suppressing). Effective outcomes of the
mentioned publications are also presented (in italic).
*MLA – Multi Locus Assessment; Lab stands for laboratorial and Model stands for computational modelling.
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non-vector insects (202),(9),(6),(215),(8),(219),(223),
(225).
Technique (anti-pathogen transgenesis)
A subsequent blockage or reduction of pathogen
transmission was reported in Aedes aegypti (208),
(211),(212), in Anopheles gambiae (204),(213),(222),
Anopheles stephensi (207),(214),(221), and in the silk-
worm Bombyx mori (225). However, in one publi-
cation the Plasmodium falciparum protection
induced by an anti-malarial gene was inconsistent
(213).
Fitness (anti-pathogen transgenesis)
In some cases, the anti-pathogen transgene led to no
or low fitness cost in the modified insects (208),
(222), thus allowing the modified insect to be repro-
ductively competitive against their natural counter-
parts. However, anti-pathogen gene insertion also
caused fitness benefits in Anopheles gambiae (206),
and Anopheles stephensi that fed Plasmodium-infected
blood (207),(221). Since these outcomes increase vec-
tors abundances and vectorial capacity, they consti-
tute reversal outcomes.
Release (anti-pathogen transgenesis)
Several publications, all of them computational model-
ling or laboratorial studies, estimated successful release
of insects modified with an anti-pathogen transgene
(7),(207),(4),(220),(221),(224). Some out of those
described the efficacy of different gene drives (which
bias the inheritance of a particular gene to quickly
and irreversibly spread it through a population) such
as, Multi-locus assortment (209), Medea and Killer-
Rescue (220), and Wolbachia (7),(4),(9),(5). Two
publications presented comparative studies describing
advantages and disadvantages of several gene drives
(6),(8). Numerous computational modelling studies
suggested a hard compromise between invasiveness
and confinement (a high migration rate required to
become established in neighbouring populations, and
low frequency persistence in neighbouring populations
for moderate migration rates) (209),(220),(7),(4),(9),
(5),(6),(8). Wolbachia was referred as an efficient
gene drive in some studies (9),(7),(5),(4) but according
to Marshal and Hay, 2012 (8), was not reliable for
confinement properties. Semele, Merea and two-locus
engineered under-dominance were the most promising
in confinement properties and required lower intro-
duction frequencies (compared to Wolbachia, Medea,
single-allele under-dominance, single-locus engineered
under-dominance, and killer-rescue) (8). Multi Locus
Assessment, despite being less effective as gene drive,
allows the test of ecological components before releases
with more invasive gene drives (209).
Modification and Technique (lethal transgenesis)
Successful insertion of a lethal transgene was reported
in Aedes aegypti (226), Drosophila melanogaster (230),
and Ceratitis capitata (228) and subsequent lethality
was laboratorial confirmed in Aedes aegypti (226) and
Drosophila melanogaster (230).
Fitness (lethal transgenesis)
One publication reported no fitness costs caused by the
modification on the modified insect and confirmed that
the lethal transgene did not affect insecticide suscepti-
bility (228).
Figure 5. Distribution of the publications regarding Transgenesis and other non-symbiont-based modification strategies, whose
results contribute to each efficacy topic, distinguishing effective/ineffective outcomes (n = 37).
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Table 3. Main effective outcomes of transgenesis and other non-symbiont-based insect modification (vector insect species).
Species Wolb strain (Modification) Technique (Pathogen protection) Fitness Release Type of Study Reference
Aedes aegypti wAlbA and
wAlbB
Stable
transinfection
higher fecundity females Lab and Model Ruang-areerate and
Kittayapong, 2006 (13)
wMelPop not applicable net increase in mosquito numbers may
occur
Lab and Model Jeffery et al., 2009 (100)
wAlbB Stable
transinfection
(inhibit DENV2 infection) increased longevity Lab Bian et al., 2010 (90)
Aedes albopictus wAlbA &
wAlbB
(natural) live longer, produce more eggs, and have
higher hatching rates
eventual undesirable increase in the
density of adult population
Lab, semi field
and Model
Dobson et al., 2002 (93)
wAlbA and
wAlbB
natural,
introgressed
longer lived, higher egg hatch in compatible
crosses, and more fecund
Lab Dobson et al., 2004 (74)
under low competitive pressures, females
experience higher survivorship
Lab Gavotte et al., 2010 (92)
Aedes fluviatilis wFlu (natural) enhances oocyst infection of
plasmodium gallicaceum
Lab Baton et al., 2013 (80)
An. gambiae wAlbB somatic infection increases plasmodium berghei
oocysts
Lab Hughes et al., 2012a (58)
An. stephensi wAlbB Somatic
transinfection
plamodium yoelii (increased
oocysts at 24°C)
Lab Murdock et al., 2014 (84)
wAlbB Increased life span (sugar meals), despite
reduced fecundity
Lab Joshi et al., 2014 (41)
Culex pipiens wPip protection from Plasmodium-induced
mortality
Lab Zélé et al., 2012 (95)
wPip (ARwp
line)
increasing plasmodium relictum
transmission stages
Lab Zélé et al., 2014 (89)
Culex
quinquefasciatus
wPip (natural) live longer, lay eggs earlier and higher
hatching rates
Lab Almeida et al., 2011 (94)
Culex tarsalis enhanced WNV infection (not
transmission)
Lab Dodson et al., 2014 (42)
Note: Publications reporting effective outcomes on the topics: release, epidemiology and long-term (the ones closer to the strategy’s aim, that is transmission blockage or vector suppressing). Ineffective outcomes of the mentioned publications
are also presented (in italic). Lab stands for laboratorial, Model stands for computational modelling, and NA stands for not applicable.
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Release (lethal transgenesis)
Computational modelling studies reported that the
elimination of vector insects might be an unrealistic
objective. However, substantial suppression can none-
theless be achieved in certain conditions, such as a uni-
form spatial pattern and multiple lethal elements (227),
or a certain release ratio and population size (229),
(224). Elimination of a natural population after the
release of insects with a dominant lethal was though
reported in a semi-field study (228).
Long-term (lethal transgenesis)
One computational modelling study suggested lethal
transgenesis long-term efficacy be compromised by
invasion of wild type insects (224).
From all publications in this section, only one pub-
lication reported a field study, describing the ability to
mate and copulate of a radiated insect, modified by a
sterilizing technique (SIT) (231). Also only three pub-
lications reported reversal outcomes, related to fitness
benefits (as above mentioned). Main effective outcomes
of transgenic and other non-symbiont-based modified
insect vectors are presented in Table 3 (the complete
data is presented in S2 Table).
Five articles (2.1% out of the 237 with efficacy out-
comes) contributed to the efficacy of insect
modification as a vector control approach, regardless
of the modification strategy used (see S8 Table). They
reported results as diverse as: effective releases, in
what concerns numbers of insects, and sex ratio,
(233), the impact of laboratory rearing (234), or
descriptions of gene flow of eventual release sites
(235–237). Interestingly, in all analysed publications
regarding gene flow, no isolation was found between
Islands and mainland, neither in Society Islands of
French Polynesia (236), nor Lake Victoria in Western
Kenya (235), nor in Bijagós archipelago in Guiné-Bis-
sau (237).
Effects
Apart from the intended effective traits, modifications
also induce other effects into the insects, as reported
in 155/44.4% publications (nTotal = 349). Modifi-
cations induced effects at several levels: (i) at the speci-
men level, i.e. physiological effects such as
reproduction, immune response, or microbiome of
the modified insect; (ii) at the insect species level, con-
cerning its evolution and/or behaviour; and (iii) at the
ecosystem level, affecting any other organism of the
modified insect ecosystem (Figures 2 and 6).
Figure 6. Number of publications reporting each Wolbachia-induced effect per taxonomic group.
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Majority of publications contributing to this theme
covered effects specifically induced by Wolbachia and
as a natural infection. There were two exceptions
only, all of them reporting population effects: one pub-
lication describing effects on evolution, induced by
other symbiont (natural infection of Rickestia) (1),
and one publication describing loss of assortative mat-
ing induced by laboratory rearing (234).
Physiological effects (at the insect specimen
level)
A total of 63/18.1% publications (nTotal = 349)
reported that insect modification strategies may induce
physiological effects on the target insect. The most fre-
quent physiological effects found in analysed publi-
cations were Wolbachia-induced effects on
reproduction. The following reproductive modifi-
cations were reported: (i) male-killing (the death of
male embryos during early embryonic development,
with advantage for the surviving infected female sib-
lings), stated in four non-vector species (Ephestia Kue-
heniella – butterfly, Hypolimnas bolina- butterfly,
Ostrinia scapulalis moth, and Tribolium madens – bee-
tle) (53),(54),(155),(238–240); (ii) feminization (the
conversion of genetic males into functional females),
described in two non-vector species (Eurema hecabe
and Zyginidia pullula) (241–243),(172); and (iii)
parthenogenesis (the exclusive participation of females
on reproduction, and production of female offspring),
reported in several species of parasitoid wasps (173),
(244),(245). Although cytoplasmic incompatibility
(CI) can be considered a Wolbachia reproductive
effect, since it is a required trait for Wolbachia use as
control strategy, it was herein considered an efficacy
trait rather than a reproductive effect (see CI results
on Technique topic). Moreover, effects on reproduc-
tion also included sex ratio alterations (246),(157),
(247),(248), exceptional sex mosaics (168), requirement
of Wolbachia for oogenesis (130),(131), or changes in
expression of genes associated with reproduction
(249),(172).
Wolbachia also induced effects on the immunity of
the modified insect mainly through the up-regulation
of effector genes. Report ofWolbachia-mediated induc-
tion of immune system was described in Aedes aegypti
(14),(90),(250),(187),(251),(23), Aedes albopictus (252),
(253),(35), Aedes polyniensis (37), Anopheles gambiae
(254),(253),(57), Anopheles stephensi (40), and Droso-
phila melanogaster (250),(249). Wolbachia also induced
reduction of the immune response by decreasing the
ability to encapsulate parasitoid eggs in Drosophila
simulans (161) or decreasing the ability to produce
lead peroxides (255).
Other physiological effects were also reported, such
as, alteration in the insect’s microbiome, (164),(138),
(150),(39),(256), gene expression (genes, microRNA,
sRNA, or epigenetic effects), (172),(257),(249),(258–
260), or in its nutrition and metabolic mechanism
(261),(170),(71),(262–265),(129),(249),(266),(267),(137),
(195), see all information regarding physiological effects
(also (268),(269),(182),(270),(189),(271)) in S4 Table.
Populational effects (at insect population level)
According to 40/11.5% analysed articles (nTotal =
349), Wolbachia also affected its host population in
several ways such as altering its mitochondrial DNA
(mtDNA) pattern, interfering in speciation process,
on its behaviour ecology, or others. Changes in
mtDNA patterns were reported in several non-vector
insects (272–283), and in the vector mosquito Culex
pipiens (7). Phylogenetic analysis of Culex pipiens com-
plex populations from three continents indicated a
Wolbachia-induced drastic reduction of mitochondrial
variability, thus profoundly interfering in its popu-
lation structure (7). Several articles suggested thatWol-
bachia induced speciation, altering genomic diversity
(284), leading to premating behavioural isolation
(285),(286) or to reproductive divergence (due to vari-
able phenotypic effects) (10). Wolbachia-induced
behavioural isolation is more likely in diploid and hap-
loid than in haplodiploids hosts (287), and can be more
evident in hybrid zones (288). Examples of behavioural
changes, all of them reported in non-vector insects or
suggested by computational modelling studies, are
the sex-role inversion on reproductive ritual (246),
the increase of sexual promiscuity (159),(289), and
the irreversible loss of sexual reproduction (290),
(173),(291).
Symbiont-induced speciation was also reported in
Neochrysocharis formosa infected with Rickestia (1).
All data regarding populational effects (also (292),
(293),(160),(170),(247),(294), (172),(295),(144),(296–
299)) is presented in S5 Table.
Ecological effects (at insect ecosystem level)
Finally, 64/18.3% publications reported thatWolbachia
is also able to induce alterations in other organism
rather than its host, interfering thus, with the host eco-
system. The majority of the publications covering this
type of effect described the report or the estimation
of horizontal transfer events (i.e. transfer between
neighbouring contemporary species) of genetic
material, such as a gene or a symbiont. Horizontal
transfers (HT) can occur through bacteriophages, para-
sitoids, hemolymph, etc. Reported HT events comprise
innumerous type of transfers such as between
symbionts (300),(292),(301), (302–304),(137), from
Wolbachia to insect vector (305–309), from Wolbachia
to nematode species (305), from insect to insect
(155),(116),(310–312),(118),(313),(294),(107),(314),(248),
(315–320),(296),(321–324),(201), and from insect to
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non-insect species (325),(326), insect to bacteria (327).
All data regarding HT (also (328),(329),(119),(167),
(305),(330),(122),(331),(302),(245),(325),(332),(333),(307),
(334–339)) are described in S6 Table.
Apart from HT, Wolbachia can reach other organ-
isms also inducing ecological effects. All publications
reporting non-HT ecological effects consisted of
studies in mammals. Those had contact with Wolba-
chiamainly via filarial infection. AWolbachia-infected
filarial nematode induced or exacerbates filarial dis-
eases pathogenesis such as human subcutaneous dirofi-
lariasis (340), onchocerciasis (river blindness) (341),
(342), and lymphatic filariasis (343),(344) (Table 4).
Discussion
To our knowledge, the present work constitutes a
unique review on modified insects for vector-borne
disease prevention. Rather than being the perspective
of an author or a summary of the authors’ selection
of publications, this review followed a structured meth-
odological procedure. Furthermore, authors from the
present review are not involved in scientific projects
to modify insects having, thus, no conflict of interest
in the outcomes of this reflection. Moreover, the pre-
sent review enclosed several types of modifications in
any vector or non-vector insect species, covering an
uncommon comprehensiveness, and thus, offering an
exceptional opportunity to observe trends and to out-
line the big picture of the modified insects. Non-vector
insects were included since most studies regarding
techniques are first performed in model insects, such
as Drosophila spp., before being applied on vector
insects. Also, it goes beyond modifications’ efficacy,
most commonly covered in current reviews [14,15],
exploring research articles also related to modifi-
cations’ non-target effects and even the variability of
the efficacy outcomes in different settings. Finally, it
is to our knowledge the sole review on the subject
including publications on mammals and exploring
the eventual non-target effects of insects’ modifications
on this important taxonomic group.
Efficacy of the modifications was the most covered
theme, being analysed in 237 out of the 349 publi-
cations included in the review. Nevertheless, the
amount of publications regarding modifications’
efficacy does not reflect the extent either the robustness
of the evidence available regarding it. Out of those 237,
only 41 publications reported main effective outcomes:
successful releases of modified insects, its positive epi-
demiological impact and/or its long-term efficacy (the
remaining 196 cover ineffective or primary effective
Table 4. Other ecological effects: publications reporting Wolbachia-induced effects on mammals and respective main results.
Wolbachia Origin Results
Analysed Mammal
cells Related disease
1st author,
year
Catle
(cows)
via Nematode Pathogen
(Onchocerca armillata)
Presence of Wolbachia confirmed in aorta
sections from different Onchocerca
Armilla-infected animals
tissue sections of
infected animals
Onchocerciasis (river
blindness)
Neary et al.,
2011 (345)
Cats via Nematode Pathogen
(Dirofilaria immitis)
Dirofilaria immitis infection leads to an
immune response against Wolbachia
proteins
Sera cats and owners’
cats
heartworm disease
(cats/dogs)
Bazzocchi
et al., 2000
(346)
via Nematode Pathogen
(Dirofilaria immitis)
Wolbachia-induced a greater acute
inflammatory response worsening the
broncho-reactivity
infected and non-
infected breathing
patterns
heartworm-
associated
respiratory disease
(cats/dogs)
García-Guasch
et al., 2013
(347)
Humans via Nematode Pathogen
(Wuchereria bancrofti)
anti-Wolbachia surface protein antibody
responses are associated with the
presence of chronic filarial morbidity
human serum
samples
Lymphatic filariasis Punkosdy
et al., 2003
(344)
via Nematode Pathogen
(Dirofilaria repens)
specific immune response toWolbachia in
patients; Wolbachia may indeed
participate in granuloma formation
human skin nodules Human subcutaneous
dirofilariasis
Grandi et al.,
2008 (298)
via Nematode Pathogen
(Wuchereria bancrofti)
Wolbachia surface protein may also
contribute to the suppression of
immune responses seen in filarial
patients
human patients
blood
Lymphatic filariasis Shiny et al.,
2012 (348)
(artificially introduced)
neutrophil cell lines
with Wolbachia
lipopolysaccharides (LPS)
Wolbachia is a major contributing factor
in the development of chronic
pathology in humans
blood neutrophils
from adult healthy
volunteers
Onchocerciasis (river
blindness)
Tamarozzi
et al., 2014
(300)
unknown twice detection in 5days of Wolbachia
genes in human patient with an
unknown infection. Later detection of a
non-Hodgkin’s lymphoma
blood of a patient
with apparent viral
infection
symptoms
non-Hodgkin’s
lymphoma
Chen et al.,
2014 (349)
Mice via Nematode Pathogen (Brugia
malayi)
Wolbachia-mediated neutrophil
activation is an important mechanism
to visual impairment and eventual
blindness in ocular onchocerciasis
mouse cornea and
peritoneal cavity
neutrophils
Onchocerciasis (river
blindness)
Gillette-
Ferguson
et al., 2004
(299)
Cell lines (artificially infected) (Wolbachia
from Brugia malayi)?
Wolbachia lipopolysaccharides (LPS) may
be one of the major mediators of
inflammatory pathogenesis in filarial
nematode disease
murine macrophage
and mosquito
cultures
Lymphatic filariasis Taylor et al.,
2000 (301)
Note: Publications reporting effective outcomes on the topics: release, epidemiology and long-term (the ones closer to the strategy’s aim, that is transmission
blockage or vector suppressing). Ineffective outcomes of the mentioned publications are also presented (in italic).
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outcomes). Out of the three main efficacy topics, the
epidemiological impact was the less covered, reported
in only five publications, none of them based on the
most robust field studies, but all based on compu-
tational modelling studies instead. In fact, results
based on modelling results may not be the same
when tested in the field (since no modelling study con-
sider all variables of a real environment). Also, results
on the release of the modified insects may not persist
in the long-term neither mean an actual change on dis-
ease transmission.
According to the epidemiology definition, efficacy
determines whether an intervention produces the
expected result under ideal circumstances, while effec-
tiveness measures the degree of beneficial effect under
actual settings [16]. This works explored efficacy
(modification, technique, and fitness) and effective-
ness-related topics (release, epidemiology, long-term
and variability). However, to simplify classification,
“efficacy” was used as a broad term that included all
above-mentioned topics.
Main effective outcomes were obtained for several
insect modifications, namely, Wolbachia-based strat-
egies (replacement and suppression approaches),
RIDL, and female killing lethal transgenesis (both sup-
pression approaches), computational modelled trans-
genesis regardless of the transgene (replacement and/
or suppression approaches), and paratransgenesis
(replacement approach). Seven publications (out of
the 41) reported main effective outcomes based on
semi-field or field studies (corresponding to outcomes
obtained with Wolbachia or RIDL strategies). Even
though not many, these publications achieved critical
outcomes such as (i) field-released wMel-aegypti mos-
quitoes not only reached near fixation (despite a per-
sistent low frequency of uninfected mosquitoes), but
also maintained their effective traits such as CI, fixation
and pathogen protection for at least two years after the
release (27)(28) (from S1 Appendix); (ii) weekly intro-
duction of Aedes albopictus males with a dominant
lethal (RIDL) led to the eradication of a laboratory
cages population in 10–20 weeks (228) (from S1
Appendix).
The present review also described reversal outcomes
obtained after the release of transgenic insects or
insects modified with Wolbachia (reported in 39 pub-
lications). Out of those, only one publication corre-
sponds to a field study, but in this case, the release of
modified insects may lead to an increase in the vector
insect population, particularly if occurring when its
natural abundance is at its maximum [17] (also (100)
from S1 Appendix).
No publication was found directly reporting the
non-target effects of modification strategies. Analysed
publications reported biological effects (at physiologi-
cal, populational, and ecological level) of natural Wol-
bachia suggesting eventual non-target effects of
Wolbachia-based insect modifications (no publications
reporting eventual effects of transgenesis and other
non-symbiont modifications were found the systematic
review until March 2016). The effects on mammals
should be particularly and carefully explored. Monitor-
ing of an eventual increase of lymphatic filariasis sever-
ity, non-Hodgkin’s lymphoma incidence, or
unrecognized infections may be advised in areas
already subjected to Wolbachia-insects releases. Since
the inclusion criteria were restricted to studies on
insects and mammals, results regarding ecological
effects may be limited. Horizontal transfer events of
Wolbachia genetic material to non-insect non-mam-
mal species were even though reported (305),(325),
(326) (from S1 Appendix).
The Wolbachia modification technique was the
most present in this review. These results do not
reflect the actual amount of studies of some tech-
niques such as RIDL or SIT. Wolbachia is a natural
bacterium, and thus Wolbachia-based strategies are
much more accessible for study. Regarding transgenic
insects, modified strains are patented and often are
published with a code name such as OX3604C that
escapes to the search expression. Moreover, besides
those studies specifically oriented for a Wolbachia-
based strategy, other studies regarding Wolbachia
were included (mainly regarding natural Wolbachia)
whenever their results contributed to the efficacy or
the effects of Wolbachia as a vector control strategy.
Furthermore, Wolbachia is a unique term while for
transgenesis each strategy may try a different trans-
gene, with a particular effect originating several
diverse terms that may not all be covered in research
expressions. Also, regarding radiation-based modifi-
cations, such as SIT, some publications may have
been excluded during 1st screening since their
efficacy results concern studies of the modified insect
for agriculture purposes (and not for disease preven-
tion). Due to the high number of articles found
initially (1204) the application of exclusion criteria
was critical to turn the analysis feasible.
Even though there were not found publications
reporting eventual effects of transgenesis and other
non-symbiont modifications, some of their effects
were already discussed in the literature. In what con-
cerns suppressing strategies, such as RIDL (lethal trans-
genesis), female killing (lethal transgenesis), SIT, or
RNAi-mediated sterilization, the elimination of a
species leads to profound changes in its ecosystem,
such as eventually putting some non-target species in
risk or giving opportunity to not-targeting species to
expand [18,19]. Moreover, some authors have been
arguing that biodiversity loss may even be associated
with emergence of vector-borne diseases [20,21].
Regarding replacement approaches, such as anti-patho-
gen transgenesis, the effects of the transgene in the eco-
system are unknown. When associated withWolbachia
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Box 1. Top 12 articles covering critical evidence regarding modified mosquitoes for disease prevention, published after March 2016 (non-systematic selection of articles). Main findings are presented
following the same analysis scheme used in the present systematic review.
Efficacy (Non-target) Effects
Species
Modifying
technique Modification/Technique/Fitness Release/Epidemiology Long-Term/ Variability Physiological Population Ecological
Type of
Study Reference
Aedes
aegypti
Transgenesis
(RIDL)
Re-infestation by wild type mosquitoes 4–5
months after the release.
Field Garziera et al.,
2017 [27]
Other
transgenesis
(CRISPR/Cas9)
Generation of multiple stable,
transgenic mosquito strains
expressing Cas9 in the germline
Lab Li et al., 2017
[22]
Wolbachia wAlB-mosquitoes successfully
established and reduced human
dengue incidence was registred
wAlB frequencies remained high and stable at
some sites
Field Nazni et al.,
2019 [31]
Wolbachia wMel-mosquitoes successfully
established across 66 km2 and no local
dengue transmission was registred
Establishment persisted over 28 months Field O’Neill et al.,
2019 [32]
Anopheles
gambiae
Other
transgenesis
(CRISPR/Cas9)
Reaching 100% prevalence within 7–11
generations leading to total
population collapse
Semi
field
Kyrou et al.,
2018 [23]
Aedes
aegypti
Wolbachia The field-reared mosquitoes have
greater wMel-mediated inhibition of
DENV infection than their lab-reared
counterparts.
Lab
and
Field
Carrington
et al., 2017
[25]
Wolbachia wMel-mosquitoes with pyrethroid resistant
genetic background have successfully
established, despite fitness cost (contrary to
their susceptible counterparts)
(also
affecting
here)
Lab
and
Field
Garcia et al.,
2019 [21]
Aedes
aegypti
Wolbachia ZIKV and ZIKV/DENV co-
infection transmission blockage
Lab
and
Field
Caragata and
Rocha, 2019
[26]
Wolbachia Detection of natural/native Wolbachia in Ae.
aegypti
Field Carvajal et al.,
2019 [29]
Transgenesis
(RIDL)
Rare viable offspring was produced from
sterile transgenic male, generating
new hybrid mosquito population
(also
affecting
here)
Lab
and
Field
Evans et al.,
2019 [30]
Wolbachia Decline and loss of Wolbachia density from wolb-
modified mosquitoes in field
Lab
and
Field
Ross et al., 2019
[28]
Aedes
albopictus
SIT and Wolbachia Radiation- and wolb-based modified
mosquitoes almost eliminate field
mosquito population
Field Zheng et al.,
2019 [24]
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as gene drive, there are emerging questions regarding
the lateral transfer of the inserted transgene to Wolba-
chia itself or via Wolbachia to other organisms.
In what concerns the year of the publications it is
clear how recent this topic is, being almost the totality
been published in the last 20 years. This can, at least
partially, explain why in several topics we found a
gap of knowledge, such as the long-term efficacy or
the epidemiological impact of the modifications.
This hot topic is the subject of several publications
each month. An equivalent search applying the same
Mesh Terms founds more than 1250 articles that
have been published since March 2016 until 2019.
Thus, systematic reviews of proliferous subjects as the
present one are, by definition, always delayed regarding
current knowledge. However, they are of paramount
importance since they constitute a baseline of knowl-
edge that not only point out to questions that may
need to be further explored, but also can be fed with
forthcoming publications to follow up trends. More-
over, the present review developed a framework of
themes, topics and outcomes, offering an analysis
scheme that may facilitate future updates. Evidence
to support these conclusions can be found when
exploring recent important articles. We selected
(non-systematically) 12 relevant articles published
since March 2016 until now [22–32]. Critical successful
evidence was reported, mainly field-based: (i) first
stable transgenic CRISPR/cas9 aegypti-mosquitoes
strain [23]; (ii) transgenic Anopheles population col-
lapse in semifield using CRISPR/Cas9 [19]; (iii) near
elimination of field mosquitoes after release of irra-
diated and Wolbachia-infected mosquitoes [24]; (iv)
higher virus blockage of Wolbachia-infected field-
reared mosquitoes [25]; (v) wolbachia-mediated patho-
gen inhibition for ZIKV and ZIKV/DENV co-infection
[26]; and (vi) releasedWolbachia-aegypti stable over 12
months and 28 months at some sites, and reduced
human dengue incidence [27,28]. However, the most
needed effective epidemiologic and long-term out-
comes are still absent or scarce. On the contrary, recent
articles reinforced questions regarding long-term
efficacy with reports of post-release re-infestation of
wild type mosquitoes [29], and post-release loss of
Wolbachia from modified mosquitoes [30]. Recent
critical evidence also comprise the detection of wolba-
chia in A. aegypti [31], and the successful field estab-
lishment of pyrethroid-resistant modified mosquitoes
[22], and the surprising generation of hybrid mosquito
after sterile mosquito release [32]. These findings
reinforce the complexity implicit on modifying preven-
tive strategies and the eventuality of unpredictable and
irreversible effects. Even though these articles were not
included in the systematic review, their main findings
are presented in Box 1, following the same analysis
scheme of themes, topics, and outcomes presented in
Figure 1.
In conclusion, insect-modification strategies appear
as a promising innovative alternative to overcome an
unprecedented increase of vector-borne, mainly arbo-
viral, diseases. Nevertheless, these modification tools
still lack field evidence, mainly regarding epidemiologi-
cal and long-term efficacy.
Field releases in endemic areas could hopefully pro-
vide that kind of missing epidemiologic and long-term
evidence. However, unintended effects such as reversal
outcomes on disease transmission, or irreversible bio-
logical effects (including effects on mammals) need to
be explored, dispelled, or resolved. This leads to
demand for studies before open release assays. Semi-
field evidence may have a relevant role in this impasse.
Since we could only have a robust knowledge, if these
strategies would be implemented, health authorities
should reflect to what extent and in which circum-
stances the risk is worth value.
The level of variability of existing evidence suggests
the need to generate local/specific evidence in each set-
ting of an eventual release. Importantly, available pre-
ventive strategies should not remain on hold while
modified insects do not offer an effective and safe sol-
ution. This reflects the huge dilemma that is under the
use of modified insects to prevent vector-borne dis-
eases. A comprehensive cost-effectiveness analysis
could be an important tool when deciding to proceed
or not with these innovative strategies, and/or to
improve traditional available strategies.
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